Capital Fund Management (CFM)
SLDB icon

Capital Fund Management (CFM)’s Solid Biosciences SLDB Stock Holding History

Capital Fund Management (CFM)’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,240
Closed -$107K – 1867
2019
Q2 		$107K Buy
+1,240
New +$135K ﹤0.01% 1553

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Capital Fund Management (CFM)'s SLDB Position: Q3 2019 in Review

Capital Fund Management (CFM) sold out of Solid Biosciences (SLDB) in Q3 2019, closing a stake of 1,240 shares — an estimated $107K sold.

Capital Fund Management (CFM) first reported a position in SLDB in Q2 2019 and held it in 1 quarter. The position peaked at $107K in Q2 2019. 69 funds tracked by Wall St. Rank hold SLDB as of Q3 2019.

  • Capital Fund Management (CFM) reported no remaining Solid Biosciences position as of Q3 2019 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 1,240 Solid Biosciences shares in Q3 2019, an estimated $107K.
  • Capital Fund Management (CFM) first reported a position in Solid Biosciences in Q2 2019 and held it in 1 quarter.
  • Capital Fund Management (CFM)'s Solid Biosciences position peaked at $107K in Q2 2019.
  • 69 funds tracked by Wall St. Rank held Solid Biosciences as of Q3 2019.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2019, filed 13 Nov 2019.